Table 1 Lymphocyte subsets of the two groups at enrolment
DG | non-DG | ||
|---|---|---|---|
(N = 6) | (N = 19) | p | |
CD19 + B counts (cells/uL) | 164 (94–215) | 160 (142–206) | 0.799 |
CD19 + B percentage(%) | 8.75 (5.68–13.6) | 9.9 (7.8–12.9) | 0.525 |
CD16CD56 + NK counts (cells/uL) | 250 (153–315) | 137 (82–178) | 0.092 |
CD16CD56 + NK percentage (%) | 13.5 (7.1–19.2) | 8.8 (5.1–10.4) | 0.143 |
CD3+ T counts (cells/uL) | 1048 (924–1717) | 1367 (1166–1536) | 0.340 |
CD3+ T percentage (%) | 71.2 (64.6–78.2) | 79.9 (75.7–83.7) | 0.011 |
CD3 + CD4 + T counts (cells/uL) | 440 (432–616) | 510 (472–572) | 0.105 |
CD3 + CD8 + T counts (cells/uL) | 574 (358–1184) | 733 (570–856) | 0.445 |
CD4 + CD45RA-(cells/uL) | 225 (211–337) | 291 (233–367) | 0.181 |
CD4 + CD45RA + CD62L+(cells/uL) | 212 (193–279) | 188 (154–259) | 0.408 |
CD8 + HLA-DR+/CD8 + (%) | 36.9 (25.8–59.7) | 32.6 (26.6–45.0) | 0.408 |
CD8 + CD38/CD8 + (%) | 62.1 (52.2–70.5) | 48.0 (37.3–59.0) | 0.03 |
CD4/CD8 | 0.76 (0.41–1.7) | 0.75 (0.55–0.97) | 0.949 |